These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 741439)

  • 1. Congenital dysfibrinogenemia: fibrinogen Lille.
    Denninger MH; Finlayson JS; Reamer LA; Parquet-Gernez A; Goudemand M; Menache D
    Thromb Res; 1978 Sep; 13(3):453-66. PubMed ID: 741439
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of fibrinopeptide B release: comparison of fibrins produced by thrombin and Ancrod.
    Shen LL; Hermans J; McDonagh J; McDonagh RP
    Am J Physiol; 1977 Jun; 232(6):H629-33. PubMed ID: 879301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrinogen Bondy: a new case of dysfibrinogenemia. Isolation of the abnormal fibrinogen molecules.
    Jandrot-Perrus M; Aurousseau MH; Rabiet MJ; Josso F
    Thromb Res; 1982 Sep; 27(6):659-70. PubMed ID: 6217586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel variant fibrinogen, AαE11del, demonstrating the importance of AαE11 residue in thrombin binding.
    Kaido T; Yoda M; Kamijo T; Arai S; Yamauchi K; Okumura N
    Int J Hematol; 2021 Nov; 114(5):591-598. PubMed ID: 34333754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Familial dysfibrinogenemia with abnormal nonomer aggregation. Paris III fibrinogen].
    Soria J; Soria C
    Pathol Biol (Paris); 1974 Nov; 22 suppl():72-9. PubMed ID: 4620099
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinogen Kawaguchi: an abnormal fibrinogen characterized by defective release of fibrinopeptide A.
    Matsuda M; Saeki E; Kasamatsu A; Nakamikawa C; Manabe S; Samejima Y
    Thromb Res; 1985 Feb; 37(3):379-90. PubMed ID: 3992527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen Aarhus--a new case of dysfibrinogenemia.
    Hessel B; Stenbjerg S; Dyr J; Kudryk B; Therkildsen L; Blombäck B
    Thromb Res; 1986 Apr; 42(1):21-37. PubMed ID: 2939591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the sequence of fibrinopeptide A cleavage from fibrinogen fragment E by thrombin, atroxin, or batroxobin.
    Meh DA; Siebenlist KR; Bergtrom G; Mosesson MW
    Thromb Res; 1993 Jun; 70(6):437-49. PubMed ID: 8362369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired dysfibrinogenaemia in acute and chronic liver disease.
    Lane DA; Scully MF; Thomas DP; Kakkar VV; Woolf IL; Williams R
    Br J Haematol; 1977 Feb; 35(2):301-8. PubMed ID: 870000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low solubility fibrinogen examined by two-dimensional sodium dodecyl sulfate gel electrophoresis and isoelectric focusing.
    Weinstein MJ; Deykin D
    Thromb Res; 1978 Sep; 13(3):361-77. PubMed ID: 741433
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinogen New Orleans: hereditary dysfibrinogenemia with an A alpha chain abnormality.
    Andes WA; Chavin SI; Beltran G; Stuckey WJ
    Thromb Res; 1982 Jan 1-15; 25(1-2):41-50. PubMed ID: 6801812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of ancrod, the coagulating enzyme from the venom of Malayan pit viper (A. rhodostoma) on prothrombin and fibrinogen metabolism and fibrinopeptide A release in man.
    Bell WR; Shapiro SS; Martinez J; Nossel HL
    J Lab Clin Med; 1978 Apr; 91(4):592-604. PubMed ID: 641385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A hereditary dysfibrinogenemia: fibrinogen Awaji.
    Matsuo T; Okuno S; Mukaida T; Ueshima S; Okada K; Matsuo O
    Haemostasis; 1987; 17(1-2):89-97. PubMed ID: 3596361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfibrinogenemia and lupus anticoagulant in a patient with recurrent thrombosis.
    Al-Mondhiry H; Galanakis D
    J Lab Clin Med; 1987 Dec; 110(6):726-33. PubMed ID: 3119749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfibrinogenemia associated with liver disease.
    Palascak JE; Martinez J
    J Clin Invest; 1977 Jul; 60(1):89-95. PubMed ID: 874092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinogen Sapporo: dysfibrinogenemia characterized by the replacement of A alpha arginine-16 by histidine resulting in the delayed release of fibrinopeptide A by thrombin.
    Asakura S; Terukina S; Yamazumi K; Matsuda M; Murayama H; Higuchi A; Musashi M; Sakurada K; Miyazaki T
    Nihon Ketsueki Gakkai Zasshi; 1989 Sep; 52(6):1094-104. PubMed ID: 2588959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinogen Magdeburg I: a novel variant of human fibrinogen with an amino acid exchange in the fibrinopeptide A (Aalpha 9, Leu-->Pro).
    Meyer M; Kutscher G; Stürzebecher J; Riesener G; Lutze G
    Thromb Res; 2003 Jan; 109(2-3):145-51. PubMed ID: 12706644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Batroxobin binds fibrin with higher affinity and promotes clot expansion to a greater extent than thrombin.
    Vu TT; Stafford AR; Leslie BA; Kim PY; Fredenburgh JC; Weitz JI
    J Biol Chem; 2013 Jun; 288(23):16862-16871. PubMed ID: 23612970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which knobs fit into which holes in fibrin polymerization?
    Weisel JW
    J Thromb Haemost; 2007 Dec; 5(12):2340-3. PubMed ID: 17922803
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinogen kaiserslautern III: a new case of congenital dysfibrinogenemia with aalpha 16 arg-->cys substitution.
    Loreth RM; Meyer M; Albert FW
    Haemostasis; 2001; 31(1):12-7. PubMed ID: 11408744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.